Skip to Content

VBI Vaccines Inc VBIV

Morningstar Rating
$0.58 −0.05 (8.10%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

VBIV is trading at a 62% discount.
Price
$0.62
Fair Value
$8.37
Uncertainty
Extreme
1-Star Price
$71.79
5-Star Price
$6.54
Economic Moat
Bzhyv
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if VBIV is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$0.63
Day Range
$0.570.65
52-Week Range
$0.4516.08
Bid/Ask
$0.57 / $0.58
Market Cap
$13.50 Mil
Volume/Avg
88,084 / 150,622

Key Statistics

Price/Earnings (Normalized)
Price/Sales
0.84
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

VBI Vaccines Inc is a US-based commercial-stage, the biopharmaceutical company which is engaged in developing next-generation vaccines to address unmet needs in infectious disease and immuno-oncology. The company manufactures Sci-B-Vac product which is a hepatitis B (HBV) vaccine for adults, children, and newborns. Its products include Virus-Like Particle which is vaccine platform which allows for the design of enveloped virus-like particle vaccines that closely mimic the target viruses. The company operates through the single segment being Developing vaccines to address unmet needs in infectious disease and immuno-oncology.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Core
Total Number of Employees
196

Valuation

Metric
VBIV
Price/Earnings (Normalized)
Price/Book Value
0.68
Price/Sales
0.84
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
VBIV
Quick Ratio
0.51
Current Ratio
0.65
Interest Coverage
−13.77
Quick Ratio
VBIV

Profitability

Metric
VBIV
Return on Assets (Normalized)
−48.03%
Return on Equity (Normalized)
−139.71%
Return on Invested Capital (Normalized)
−57.96%
Return on Assets
VBIV
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRQhdd$537.7 Bil
VRTX
Vertex Pharmaceuticals IncFtgvxb$108.4 Bil
REGN
Regeneron Pharmaceuticals IncZkpvjc$104.6 Bil
MRNA
Moderna IncVdhks$33.4 Bil
ARGX
argenx SE ADRJgq$23.7 Bil
BNTX
BioNTech SE ADRPnbf$22.0 Bil
ALNY
Alnylam Pharmaceuticals IncTjdpgv$19.5 Bil
BMRN
Biomarin Pharmaceutical IncTbgmxnz$16.7 Bil
RPRX
Royalty Pharma PLC Class AHkjwfby$14.0 Bil
INCY
Incyte CorpHlkqbs$13.5 Bil

Sponsor Center